Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Zychrome - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

Zychrome

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

InterHealth Nutraceuticals, Inc. has launched Zychrome, a new form of chromium that has been shown in a randomized, double-blind, placebo-controlled study to significantly decrease insulin resistance and fasting insulin levels in diabetic subjects. Reductions of 30% were seen for both insulin parameters after three months of supplementation. Zychrome also significantly decreased inflammatory cytokine TNF-α levels by 21%. Reductions in this metabolic marker may help lead to normal insulin and blood sugar control. Zychrome is a unique form of chromium, niacin and L-cysteine called chromium dinicocysteinate, according to the company.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters